# Clinical Research on CBD’s Impact on Hippocampal Glutamate in Psychosis

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cbd-hippocampal-glutamate-modulation-psychosis/
> **Published:** 2026-03-25T21:44:39-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:57:32-04:00
> **Clinical Summary:** Explore CBD hippocampal glutamate modulation psychosis research showing CBD’s role in brain activity and memory in early psychosis risk individuals.

---

#### Clinical Takeaway

In a study of individuals at clinical high risk for psychosis, a single dose of CBD influenced the relationship between hippocampal glutamate levels and prefrontal brain activity during verbal memory tasks. This suggests CBD may work by modulating glutamate signaling in memory-related brain circuits, which are known to be disrupted in early psychosis. These findings help clarify a potential neurochemical mechanism behind CBD’s observed effects on memory function in this population.

### #19 A single dose of cannabidiol modulates the relationship between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis.

**Citation:** Shi Yiling et al. *A single dose of cannabidiol modulates the relationship between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis.* Psychiatry research. Neuroimaging. 2026. PMID: 41337954.

**Study type:** Journal Article, Randomized Controlled Trial  | 

**Topic area:** Cannabidiol  | 

**CED Score:** 10

Design: 5 Journal: 0 N: 1 Recency: 3 Pop: 2 Human: 1 Risk: -2

**Quality Gate Alerts:**
- Preclinical only

**Methodological Considerations:**
- Small sample — underpowered for subgroup analysis

**Abstract:** BACKGROUND: Cannabidiol (CBD) is being studied as a potential intervention for the people at clinical high risk for psychosis (CHR), though the mechanisms underlying its effects are not fully understood. Previous studies indicate that a single dose of CBD can normalize alterations in memory-related brain activation and modulate hippocampal glutamate levels in the early stages of psychosis. This study aimed to examine the [acute effects](https://cedclinic.com/episodic-memory-cannabis-impairment-study/) of CBD on the relationship between hippocampal glutamate levels and brain activation during verbal memory in individuals at CHR. METHODS: A total of thirty-three participants (n = 33) at CHR were randomly assigned to receive a single 600 mg dose of CBD (CHR-CBD) or a placebo capsule (CHR-PLB). Age-matched healthy controls (HC) (n = 19) received no study drugs. Participants underwent MRI scanning while performing a verbal learning task, and proton magnetic resonance spectroscopy to measure hippocampal glutamate levels. Effect of group x hippocampal glutamate interactions on brain activation was tested. RESULTS: CHR-PLB showed positive correlation between hippocampal glutamate levels and dorsolateral prefrontal cortex (dlPFC) (Pcorr. = 0.0039) activation compared to HC during both verbal encoding and recall. Under a single dose of CBD, the glutamate-dlPFC activation relationship was negative and significantly different compared to placebo in CHR individuals (Pcorr. = 0.0001) during both verbal encoding and recall. The reversed correlation in CBD group was also observed in the parahippocampal gyrus (Pcorr. = 0.0022) and amygdala (Pcorr. = 0.0019) during verbal recall. CONCLUSIONS: These findings suggest that CBD may normalise disrupted hippocampal-prefrontal glutamatergic coupling in CHR, highlighting its potential to target the neurochemical mechanisms underlying [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/).

 | 

[View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/41337954/)[DOI ↗](https://doi.org/10.1016/j.pscychresns.2025.112095)

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.

 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 

 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 
 

 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Cannabidiol Modulates Hippocampal Glutamate Function](https://cedclinic.com/cannabidiol-hippocampal-glutamate-modulation/)

Detailed exploration of how cannabidiol influences hippocampal glutamate function relevant to psychosis.

[Read More](https://cedclinic.com/cannabidiol-hippocampal-glutamate-modulation/)

[How Cannabidiol Modulates Glutamate in Psychosis Risk](https://cedclinic.com/cannabidiol-glutamate-modulation-psychosis/)

Insights into cannabidiol’s modulation of glutamate signaling in individuals at risk for psychosis.

[Learn More](https://cedclinic.com/cannabidiol-glutamate-modulation-psychosis/)

[Cannabidiol Effects on Glutamate and Learning in Psychosis Prevention](https://cedclinic.com/cannabidiol-clinical-trials-psychosis-research/)

Study on cannabidiol’s impact on glutamate and learning processes in psychosis prevention strategies.

[Explore Study](https://cedclinic.com/cannabidiol-clinical-trials-psychosis-research/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Clinical%20Research%20on%20CBD%E2%80%99s%20Impact%20on%20Hippocampal%20Glutamate%20in%20Psychosis&url=https%3A%2F%2Fcedclinic.com%2Fcbd-hippocampal-glutamate-modulation-psychosis%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcbd-hippocampal-glutamate-modulation-psychosis%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Clinical%20Research%20on%20CBD%E2%80%99s%20Impact%20on%20Hippocampal%20Glutamate%20in%20Psychosis%20https%3A%2F%2Fcedclinic.com%2Fcbd-hippocampal-glutamate-modulation-psychosis%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
